It appears, therefore, that downregulation of CCND2 is required for cell cycle progression and replication of certain cell types, and that overexpression of PICOT can lead to excessive downregulation of CCND2 expression, which might promote the cell growth in several types of human cancers. This evidence concerns the gene GLRX3 and cancer.